Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James J Gattuso

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Molecular Psychiatry|April 6, 2025
Letter to the editor: Comments on 'Striking long-term beneficial effects of single-dose psilocybin and psychedelic mushroom extract in the SAPAP3 rodent model of OCD-like excessive self-grooming' by Brownstien et al. (2024)James J Gattuso, Carey Wilson, Anthony J Hannan, et al.
The European Journal of Neuroscience|December 9, 2025
Acute Blockade of the Serotonin Transporter With Low Doses of Escitalopram Does Not Alter the Behavioural Responses to Acute PsilocybinNina Kleditzsch, James J Gattuso, Anthony J Hannan, et al.
Neurobiology of Disease|July 9, 2023
Mechanisms of pathogenesis and environmental moderators in preclinical models of compulsive-like behavioursCarey Wilson, James J Gattuso, Anthony J Hannan, et al.
Neuropharmacology|November 3, 2024
Psilocybin reduces grooming in the SAPAP3 knockout mouse model of compulsive behaviourJames J Gattuso, Carey Wilson, Anthony J Hannan, et al.
Neuropharmacology|August 19, 2023
Acute administration of the NMDA receptor antagonists ketamine and MK-801 reveals dysregulation of glutamatergic signalling and sensorimotor gating in the Sapap3 knockout mouse model of compulsive-like behaviourJames J Gattuso, Carey Wilson, Anthony J Hannan, et al.
Journal of Neurochemistry|November 29, 2023
Psilocybin as a lead candidate molecule in preclinical therapeutic studies of psychiatric disorders: A systematic reviewJames J Gattuso, Carey Wilson, Anthony J Hannan, et al.
European Journal of Pharmacology|January 26, 2025
Mice lacking the serotonin transporter do not respond to the behavioural effects of psilocybinJames J Gattuso, Carey Wilson, Shanshan Li, et al.
Sleep Advances : a Journal of the Sleep Research Society|July 22, 2024
The nature and magnitude of cognitive impairment in narcolepsy type 1, narcolepsy type 2, and idiopathic hypersomnia: a meta-analysisBrian T Harel, James J Gattuso, Robert D Latzman, et al.
Journal of Affective Disorders|June 6, 2025
Early-life social isolation stress worsens compulsive- and anxiety-like behaviour and alters gene expression in the prefrontal cortex of SAPAP3 knockout miceCarey Wilson, James J Gattuso, Maria Kuznetsova, et al.
Neuropharmacology|August 23, 2025
Chronic psilocybin administration increases sociability and alters the gut microbiome in male wild-type mice but not in a preclinical model of obsessive-compulsive disorderJames J Gattuso, Geraldine Kong, Bilgenur Bezcioglu, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Molecular Psychiatry|April 6, 2025
Letter to the editor: Comments on 'Striking long-term beneficial effects of single-dose psilocybin and psychedelic mushroom extract in the SAPAP3 rodent model of OCD-like excessive self-grooming' by Brownstien et al. (2024)James J Gattuso, Carey Wilson, Anthony J Hannan, et al.
The European Journal of Neuroscience|December 9, 2025
Acute Blockade of the Serotonin Transporter With Low Doses of Escitalopram Does Not Alter the Behavioural Responses to Acute PsilocybinNina Kleditzsch, James J Gattuso, Anthony J Hannan, et al.
Neurobiology of Disease|July 9, 2023
Mechanisms of pathogenesis and environmental moderators in preclinical models of compulsive-like behavioursCarey Wilson, James J Gattuso, Anthony J Hannan, et al.
Neuropharmacology|November 3, 2024
Psilocybin reduces grooming in the SAPAP3 knockout mouse model of compulsive behaviourJames J Gattuso, Carey Wilson, Anthony J Hannan, et al.
Neuropharmacology|August 19, 2023
Acute administration of the NMDA receptor antagonists ketamine and MK-801 reveals dysregulation of glutamatergic signalling and sensorimotor gating in the Sapap3 knockout mouse model of compulsive-like behaviourJames J Gattuso, Carey Wilson, Anthony J Hannan, et al.
Journal of Neurochemistry|November 29, 2023
Psilocybin as a lead candidate molecule in preclinical therapeutic studies of psychiatric disorders: A systematic reviewJames J Gattuso, Carey Wilson, Anthony J Hannan, et al.
European Journal of Pharmacology|January 26, 2025
Mice lacking the serotonin transporter do not respond to the behavioural effects of psilocybinJames J Gattuso, Carey Wilson, Shanshan Li, et al.
Sleep Advances : a Journal of the Sleep Research Society|July 22, 2024
The nature and magnitude of cognitive impairment in narcolepsy type 1, narcolepsy type 2, and idiopathic hypersomnia: a meta-analysisBrian T Harel, James J Gattuso, Robert D Latzman, et al.
Journal of Affective Disorders|June 6, 2025
Early-life social isolation stress worsens compulsive- and anxiety-like behaviour and alters gene expression in the prefrontal cortex of SAPAP3 knockout miceCarey Wilson, James J Gattuso, Maria Kuznetsova, et al.
Neuropharmacology|August 23, 2025
Chronic psilocybin administration increases sociability and alters the gut microbiome in male wild-type mice but not in a preclinical model of obsessive-compulsive disorderJames J Gattuso, Geraldine Kong, Bilgenur Bezcioglu, et al.
Pageof 2